Skip to site menu Skip to page content

Daily Newsletter

16 August 2023

Daily Newsletter

16 August 2023

Carle Health installs R-Zero’s UV-C air disinfection system

This initiative covers six of Carle Health's facilities, including the Carle Foundation Hospital.

August 16 2023

Illinois-based vertically integrated health system Carle Health in the US has implemented UV-C air disinfection technology from environmental health service company R-Zero in its facilities.

The technology harnesses the capabilities of UV-C light, AI, IoT-connected hardware and sensors.

This initiative covers six of the health system's facilities that include the Carle Foundation Hospital, the only Level 1 trauma centre in the region.

Carle Health’s use of R-Zero's Arc IoT-connected mobile devices, which neutralise harmful microorganisms on surfaces and in the air through UV-C light, is said to enhance the safety and quality of indoor air.

According to the vendor, its connected indoor health technology reduces the requirement for chemical disinfection in patient rooms after discharge, and in the hospital's operating rooms during night.

Currently, R-Zero's solutions are also used in schools and colleges, senior care communities, and corporate campuses, among others.

Carle Health environmental services director Bruce Osborne said: "Our partnership with R-Zero to add UV-C light disinfection to our cleaning process has increased the effectiveness of our environmental services team's efforts as we work to support consistent, clean space for clinical team members to care for patients.

"Offering a clean healthcare environment helps us continue to provide high-quality care for our community."

R-Zero CEO Jennifer Nuckles said: "We're thrilled to partner with Carle Health to deploy our UV-C disinfection technology, which will help make its facilities safer for patients, visitors, and staff."

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close